Bayer rollout
This article was originally published in The Gray Sheet
Executive Summary
Bayer rolls out its A1CNow Selfcheck, a system that allows diabetics to check their A1C levels at home, in U.S. pharmacies Feb. 16. Cleared by FDA via 510(k) on May 14, 2009, and launched in June 2009 on the Internet, the system enables diabetics to use a finger-prick blood sample to find out their A1C levels in five minutes
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.